ANDA 76104, held by Sandoz. Itraconazole.
As of Nov 21, 2026, ANDA 76104 (Itraconazole), held by Sandoz, was first approved by FDA on May 28, 2004, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 28, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Itraconazole100MG · capsule;oral | Itraconazole | Rx |
| Jun 9, 2025 | Supplement 28Labeling · Standard review | Approved | None posted |
| Oct 24, 2024 | Supplement 27Labeling · Standard review | Approved | None posted |
| Oct 24, 2024 | Supplement 25Labeling · Standard review | Approved | None posted |
| May 26, 2023 | Supplement 24Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 22Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 21Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 20Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 19Labeling · Standard review | Approved | None posted |
| Nov 17, 2015 | Supplement 18Labeling · Standard review | Approved | None posted |
| Nov 17, 2015 | Supplement 16Labeling · Standard review | Approved | None posted |
| Feb 20, 2013 | Supplement 11Labeling · Standard review | Approved | None posted |
| Mar 29, 2012 | Supplement 10Labeling | Approved | None posted |
| Jan 12, 2011 | Supplement 9Labeling | Approved | None posted |
| May 28, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters